Session I | Session II
P.L. 108-25 - United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003
On May 27, 2003, the President signed into law H.R. 1298 as P.L. 108-25, the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003. Provisions of
this new legislation would 1) require the President to establish a comprehensive,
integrated 5-year strategy to combat global HIV/AIDS, including specific objectives,
approaches and strategies; 2) assign priorities for relevant executive branch agencies; 3)
improve coordination among such agencies; and 4) project general levels of resources needed
to achieve the stated goals. This legislation also would require the President to
establish a position of HIV/AIDS Response Coordinator at the U.S. Department of State,
who would have primary responsibility for oversight and coordination of all U.S.
international activities to combat the HIV/AIDS pandemic.
Legislative Update (August 2003):
United States Leadership Against Global HIV/AIDS, Tuberculosis, and Malaria Act of 2003
For further information, go to the Thomas
For a chronology of legislation affecting NIH, refer to the NIH Almanac.